Bixiye
QP78-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa®
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Natiijooyinka Raadinta
Soo bandhiga 2381 - 2390 ee natiijooyinka 3701
Bixiye
QP83-20 Preventive Care Outreach Campaign for ACA Individual and Small Group (with Carenet Health)
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Bixiye
QP81-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Risdiplam PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Bixiye
QP79-20 Introducing the Blue Cross Blue Shield System’s New National High-Performance Network
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Bixiye
QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
2020 September Provider Press
Taariikhda barnaamijka Dhaqangalayso Agosto 19, 2020
Bixiye
QP76-20 Outlier Outpatient Therapy Management Program
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020